GAAP Accounting Format vs. Fund Method Accounting: A Comparative Analysis
CPA Publisher · 09.07.2026
DOI: 10.67283/cpapub-16e45441 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPA Publisher, online erschienen am 09.07.2026. Verfasst von Edward Mendlowitz und 1 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
This article compares traditional GAAP-format financial reporting for commercial entities with fund-method accounting used by investment companies, including private equity funds, hedge funds, mutual funds, and similar investment structures. Although both approaches operate within U.S. GAAP, they differ in reporting objectives, entity presentation, financial statement structure, revenue and expense emphasis, capital account reporting, cash flow classification, investment valuation, disclosures, estimates, and compliance considerations. The article explains how commercial-company reporting generally emphasizes consolidated performance, profitability, liquidity, and solvency, while fund accounting prioritizes investor capital accountability, fair value measurement, capital allocations, investment performance, and compliance with governing agreements and ASC 946. The comparison is intended for accountants, auditors, and financial statement users with limited exposure to fund accounting who need a practical framework for understanding the operational and reporting distinctions between the two methods.
Zitieren
APA
Mendlowitz, E., & Sanghavi, D. (2026). GAAP Accounting Format vs. Fund Method Accounting: A Comparative Analysis. CPA Publisher. https://doi.org/10.67283/cpapub-16e45441
Vancouver
Mendlowitz E, Sanghavi D. GAAP Accounting Format vs. Fund Method Accounting: A Comparative Analysis. CPA Publisher. 2026. doi:10.67283/cpapub-16e45441
BibTeX
@article{Mendlowitz2026,
author = {Mendlowitz, Edward and Sanghavi, Deven},
title = {GAAP Accounting Format vs. Fund Method Accounting: A Comparative Analysis},
journal = {CPA Publisher},
year = {2026},
doi = {10.67283/cpapub-16e45441}
}
EUVIMED